Spiros Jamas is the Senior Vice President of Therapeutic Development of our Company. He is primarily responsible for therapeutics strategy and development, clinical development and regulatory affairs. He co-founded AOBiome LLC in May 2013. He graduated from the University of Manchester, United Kingdom, with a Bachelor of Science majoring in Chemical Engineering, and from Massachusetts Institute of Technology, United States with a Master of Science majoring in food science and technology and a Doctor of Science majoring in Biotechnology.
Dr. Jamas has over 24 years of experience in the biopharmaceutical industry. From 1988 to 1999, he served as chief executive officer of Alpha-Beta Technology, Inc., a biotech company developing a first-in-class biologic immunomodulator, where he was responsible for its strategic development, clinical development and regulatory affairs. From 2001 to 2004, he served as chief executive officer of Enanta Pharmaceuticals, Inc., a biotech company which develops drugs for hepatitis C virus, where he was responsible for its strategic development and general management. From 2004 to 2009, he was a biotechnology/pharma analyst for the global fundamental strategies team of State Street Global Advisors, an asset management company, where he was responsible for stock analyses as well as clinical/regulatory due diligence. In 2010, he co-founded Tempero Pharmaceuticals, Inc., a biotech company which is now a part of the GlaxoSmithKline group, to develop drugs for inflammatory and autoimmune diseases.